Deep learning computers in a diagnostic imaging lab routinely defeat their human counterparts in diagnosing heart failure, detecting various cancers and predicting their strength.
As the volume and depth of genomic data grows, bioinformaticians are translating genomic data into interpretable patterns leading to new biological insight.
Less than half the patients diagnosed with cancer respond favourably to chemotherapy. Now, a new method for testing how patients will respond to various drugs could pave the way for more personalised treatment.
The digital audio of an entire music album is to be stored in the form of genetic information for the first time, using technology developed at ETH Zurich.
To fully benefit from the vast quantities of data from TCGA, tools for easy data visualisation and analysis must be developed for use of the non-computational scientist. Our panel of experts discuss TCGA data and the tools needed to make sense of it.
Researchers around the globe can now access thousands of paediatric cancer genomic datasets, thanks to a new cloud-based initiative.
Repositive, has successfully concluded the pilot phase of its data-sharing platform for PDX cancer models and is now extending the scope of the platform to include a wider range of translational cancer models.
Comparison of Single Nucleotide Variants in Sequencing Data Produced by Illumina and Oxford Nanopore Technologies.
Come hear from David Grieg, Bioinformatician at Public Health England to learn more about the application of the MinION for the surveillance of Shiga toxin-producing Escherichia coli O157:H7.
Searching for new drugs requires patience, skill and, of course, money. Now, researchers have developed a method to examine millions of potential self-produced drug candidates in one go.
DNA has an important job—it tells your cells which proteins to make. Now, a research team at the University of Delaware has developed technology to program strands of DNA into switches that turn proteins on and off.